NCT00460655 - Study of GSK1358820 In Patients With Post-Stroke Lower Limb Spasticity | Biotech Hunter

Enrollment

120

Participants

Timeline

Start Date

May 31, 2007

Primary Completion Date

December 31, 2008

Study Completion Date

December 31, 2008

Conditions

Post-Stroke SpasticityCerebrovascular Accident

Interventions

DRUG

GSK1358820

botulinum toxin type A

DRUG

Placebo

Trial Locations (20)

811-0213

GSK Investigational Site, Fukuoka

720-0825

GSK Investigational Site, Hiroshima

728-0001

GSK Investigational Site, Hiroshima

005-0802

GSK Investigational Site, Hokkaido

005-8555

GSK Investigational Site, Hokkaido

006-0805

GSK Investigational Site, Hokkaido

053-0803

GSK Investigational Site, Hokkaido

302-0112

GSK Investigational Site, Ibaraki

227-8518

GSK Investigational Site, Kanagawa

247-8533

GSK Investigational Site, Kanagawa

253-8558

GSK Investigational Site, Kanagawa

257-0001

GSK Investigational Site, Kanagawa

860-8518

GSK Investigational Site, Kumamoto

410-1128

GSK Investigational Site, Shizuoka

410-2507

GSK Investigational Site, Shizuoka

410-3293

GSK Investigational Site, Shizuoka

105-8471

GSK Investigational Site, Tokyo

140-0001

GSK Investigational Site, Tokyo

142-8666

GSK Investigational Site, Tokyo

740-0021

GSK Investigational Site, Yamaguchi